SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements

Detalhes bibliográficos
Autor(a) principal: Hoschler, Katja
Data de Publicação: 2022
Outros Autores: Ijaz, Samreen, Andrews, Nick, Ho, Sammy, Dicks, Steve, Jegatheesan, Keerthana, Poh, John, Warrener, Lenesha, Kankeyan, Thivya, Baawuah, Frances, Beckmann, Joanne, Okike, Ifeanichukwu O., Ahmad, Shazaad, Garstang, Joanna, Brent, Andrew J., Brent, Bernadette, Aiano, Felicity, Brown, Kevin E., Ramsay, Mary E., Brown, David, Parry, John V., Ladhani, Shamez N., Zambon, Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/50748
Resumo: Virus Reference Department, Public Health England. London. United Kingdom.
id CRUZ_fbb8e7c374c0ce4d3341ec8ff3965e97
oai_identifier_str oai:www.arca.fiocruz.br:icict/50748
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Hoschler, KatjaIjaz, SamreenAndrews, NickHo, SammyDicks, SteveJegatheesan, KeerthanaPoh, JohnWarrener, LeneshaKankeyan, ThivyaBaawuah, FrancesBeckmann, JoanneOkike, Ifeanichukwu O.Ahmad, ShazaadGarstang, JoannaBrent, Andrew J.Brent, BernadetteAiano, FelicityBrown, Kevin E.Ramsay, Mary E.Brown, DavidParry, John V.Ladhani, Shamez N.Zambon, Maria2022-01-13T14:01:50Z2022-01-13T14:01:50Z2022HOSCHLER, Katja et al. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements. Microbiology Spectrum, v. 10, n. 1, e00786-21, p. 1-12, Jan. 2022.2165-0497https://www.arca.fiocruz.br/handle/icict/5074810.1128/spectrum.00786-21engAmerican Society for MicrobiologyCOVID-19AnticorposEscolasPesquisasCriançasFluido oralAntibodyCOVID-19SchoolsSurveysChildrenOral fluidSARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurementsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleVirus Reference Department, Public Health England. London. United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Virus Reference Department, Public Health England. London, United Kingdom.Virus Reference Department, Public Health England. London, United Kingdom / Microbiology Services Laboratory, NHS Blood and Transplant. Bristol, United Kingdom.Virus Reference Department, Public Health England. London, United Kingdom / Microbiology Services Laboratory, NHS Blood and Transplant. Bristol, United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.East London NHS Foundation Trust. London, United Kingdom.Derbyshire Healthcare NHS Foundation Trust. Derby, United Kingdom.Manchester University NHS Foundation Trust. Manchester, United Kingdom.Birmingham Community Healthcare NHS Trust. Aston, United Kingdom.Oxford University Hospitals NHS Foundation Trust. Oxford, United Kingdom / University of Oxford, Oxford. United Kingdom.Oxford University Hospitals NHS Foundation Trust. Oxford, United Kingdom / University of Oxford, Oxford. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Virus Reference Department, Public Health England. London. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom / Paediatric Infectious Diseases Research Group, St. George’s University of London. London, United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Seroepidemiological studies to monitor antibody kinetics are important for assessing the extent and spread of SARS-CoV-2 in a population. Noninvasive sampling methods are advantageous for reducing the need for venipuncture, which may be a barrier to investigations, particularly in pediatric populations. Oral fluids are obtained by gingivacrevicular sampling from children and adults and are very well accepted. Enzyme immunoassays (EIAs) based on these samples have acceptable sensitivity and specificity compared to conventional serum-based antibody EIAs and are suitable for population-based surveillance. We describe the development and evaluation of SARS-CoV-2 IgG EIAs using SARSCoV- 2 viral nucleoprotein (NP) and spike (S) proteins in IgG isotype capture format and an indirect receptor-binding-domain (RBD) IgG EIA, intended for use in children as a primary endpoint. All three assays were assessed using a panel of 1,999 paired serum and oral fluids from children and adults participating in school SARS-CoV-2 surveillance studies during and after the first and second pandemic wave in the United Kingdom. The anti-NP IgG capture assay was the best candidate, with an overall sensitivity of 75% (95% confidence interval [CI]: 71 to 79%) and specificity of 99% (95% CI: 78 to 99%) compared with paired serum antibodies. Sensitivity observed in children (80%, 95% CI: 71 to 88%) was higher than that in adults (67%, CI: 60% to 74%). Oral fluid assays (OF) using spike protein and RBD antigens were also 99% specific and achieved reasonable but lower sensitivity in the target population (78%, 95% CI [68% to 86%] and 53%, 95% CI [43% to 64%], respectively).info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/50748/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALDavidBrown_KatiaHoschler_etal_IOC_2022.pdfDavidBrown_KatiaHoschler_etal_IOC_2022.pdfapplication/pdf1354207https://www.arca.fiocruz.br/bitstream/icict/50748/2/DavidBrown_KatiaHoschler_etal_IOC_2022.pdf600efc1bca3730d204618d5fc4a270bfMD52icict/507482022-01-13 12:04:56.736oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-01-13T15:04:56Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
title SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
spellingShingle SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
Hoschler, Katja
COVID-19
Anticorpos
Escolas
Pesquisas
Crianças
Fluido oral
Antibody
COVID-19
Schools
Surveys
Children
Oral fluid
title_short SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
title_full SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
title_fullStr SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
title_full_unstemmed SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
title_sort SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
author Hoschler, Katja
author_facet Hoschler, Katja
Ijaz, Samreen
Andrews, Nick
Ho, Sammy
Dicks, Steve
Jegatheesan, Keerthana
Poh, John
Warrener, Lenesha
Kankeyan, Thivya
Baawuah, Frances
Beckmann, Joanne
Okike, Ifeanichukwu O.
Ahmad, Shazaad
Garstang, Joanna
Brent, Andrew J.
Brent, Bernadette
Aiano, Felicity
Brown, Kevin E.
Ramsay, Mary E.
Brown, David
Parry, John V.
Ladhani, Shamez N.
Zambon, Maria
author_role author
author2 Ijaz, Samreen
Andrews, Nick
Ho, Sammy
Dicks, Steve
Jegatheesan, Keerthana
Poh, John
Warrener, Lenesha
Kankeyan, Thivya
Baawuah, Frances
Beckmann, Joanne
Okike, Ifeanichukwu O.
Ahmad, Shazaad
Garstang, Joanna
Brent, Andrew J.
Brent, Bernadette
Aiano, Felicity
Brown, Kevin E.
Ramsay, Mary E.
Brown, David
Parry, John V.
Ladhani, Shamez N.
Zambon, Maria
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Hoschler, Katja
Ijaz, Samreen
Andrews, Nick
Ho, Sammy
Dicks, Steve
Jegatheesan, Keerthana
Poh, John
Warrener, Lenesha
Kankeyan, Thivya
Baawuah, Frances
Beckmann, Joanne
Okike, Ifeanichukwu O.
Ahmad, Shazaad
Garstang, Joanna
Brent, Andrew J.
Brent, Bernadette
Aiano, Felicity
Brown, Kevin E.
Ramsay, Mary E.
Brown, David
Parry, John V.
Ladhani, Shamez N.
Zambon, Maria
dc.subject.other.pt_BR.fl_str_mv COVID-19
Anticorpos
Escolas
Pesquisas
Crianças
Fluido oral
topic COVID-19
Anticorpos
Escolas
Pesquisas
Crianças
Fluido oral
Antibody
COVID-19
Schools
Surveys
Children
Oral fluid
dc.subject.en.pt_BR.fl_str_mv Antibody
COVID-19
Schools
Surveys
Children
Oral fluid
description Virus Reference Department, Public Health England. London. United Kingdom.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-01-13T14:01:50Z
dc.date.available.fl_str_mv 2022-01-13T14:01:50Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv HOSCHLER, Katja et al. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements. Microbiology Spectrum, v. 10, n. 1, e00786-21, p. 1-12, Jan. 2022.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/50748
dc.identifier.issn.pt_BR.fl_str_mv 2165-0497
dc.identifier.doi.none.fl_str_mv 10.1128/spectrum.00786-21
identifier_str_mv HOSCHLER, Katja et al. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements. Microbiology Spectrum, v. 10, n. 1, e00786-21, p. 1-12, Jan. 2022.
2165-0497
10.1128/spectrum.00786-21
url https://www.arca.fiocruz.br/handle/icict/50748
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/50748/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/50748/2/DavidBrown_KatiaHoschler_etal_IOC_2022.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
600efc1bca3730d204618d5fc4a270bf
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324713772023808